Two Sigma Securities, LLC Repligen Corp Put Options Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $375,716 - $458,524	2,200 Added 88.0%	4,700 $864,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $285,425 - $463,375	2,500 New	2,500 $449,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $293,094 - $376,390	1,900 New	1,900 $319,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $577,512 - $922,355	3,600 New	3,600 $674,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $483,570 - $773,879	3,000 New	3,000 $564,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $305,856 - $392,904	-3,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $265,824 - $335,088	3,600 New	3,600 $333,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.52B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.